-
Spurs win 10th straight, Pistons silence Thunder in battle of NBA's best
-
Germany's Merz visits China AI hub hoping for business deals
-
Post-uprising polls won't shake Nepal's delicate India-China balance
-
S.Korea's Park Chan-wook to head Cannes festival jury
-
Australian ex-PM says 'more important than ever' to ditch UK monarchy
-
Dressed for succession? Kim Jong Un, daughter fuel speculation with matching coats
-
US-Ukraine talks to open in Geneva after overnight Russian strikes
-
Export ban sparks rush to process lithium in Zimbabwe
-
Pakistani sculptor turns scrap into colossal metal artworks
-
Epstein files reveal links to cash, women, power in Africa
-
Where are Southeast Asia's data centres?
-
Where AI lives: Southeast Asia's data centre boom
-
Seoul hits fresh record on mixed day for Asia markets
-
Kyiv residents pool together for solar panels and batteries amid Russian strikes
-
North Korea's Kim says could 'get along' with US but shuns South
-
Cuba kills four on US-registered speedboat trying to 'infiltrate'
-
UK Labour party threatened by hard-right, leftists in heartland
-
Australian PM sorry after saying sexual assault survivor 'difficult'
-
Kim Jong Un spurns olive branch from 'hostile' South Korea
-
DR Congo sanctuary resists bloody forest sell-off
-
North Korea looking to replicate youth success at Women's Asian Cup
-
Deal or no deal: What's the state of Trump's tariffs?
-
Hillary Clinton to testify in US House panel's Epstein probe
-
African migrants won legal protections - then Trump deported them
-
US women's ice hockey captain responds to 'distasteful' Trump remark
-
US presses missile issue as new Iran talks to open in Geneva
-
US government accused of major 'cover-up' over Trump sex abuse claims
-
US eases Cuba oil embargo but demands 'dramatic' change
-
IMF urges US to work with partners to ease trade restrictions
-
Brumbies not getting carried away by emphatic Super Rugby start
-
Cuba coast guard kills four on US-registered speedboat
-
Juve lick wounds after painful Champions League exit
-
Real Madrid victory for 'everyone against racism': Tchouameni
-
Wallabies skipper Wilson back from injury in clash of heavyweight coaches
-
PSG coach Luis Enrique calls on team to raise their game in Champions League last 16
-
Nvidia smashes forecasts with record quarter as AI boom rolls on
-
Vinicius seals Real Champions League progress as PSG edge out Monaco
-
Galatasaray survive Juve scare to squeeze into Champions League last 16
-
PSG survive Monaco scare to reach Champions League last 16
-
Vinicius hits winner as Real Madrid eliminate Benfica after racism row
-
Harden fractures thumb in blow to in-form Cavaliers
-
Hope fades in search for missing after Brazil rains kill 46
-
Trump, Zelensky speak before Ukraine-US talks in Geneva
-
Scam centres 'destroying' Cambodia's economy, PM tells AFP
-
Last-gasp Atalanta eliminate Dortmund to reach Champions League last 16
-
Iran negotiators arrive in Geneva for high-stakes US talks
-
Antonio Tejero, leader of Spain's failed 1981 coup, dies at 93
-
Hakimi, set to face trial for rape, in PSG team for Champions League game
-
Eleven men lured into Russia war returned to South Africa
-
Brazil politicians convicted for ordering murder of black activist councilor
Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Wednesday, August 20, 2025, at 11:00 a.m. ET.
Ainos will highlight the uniqueness of its AI Nose technology, underscoring recent strategic partnerships and the rapid acceleration of AI Nose deployment. In addition, the Company will also share insights into market and scale-up opportunities across multiple sectors, outline key milestones expected for the remainder of 2025 and into 2026, and make the case for why Ainos should be regarded as a technology company at its core.
To register for this listen-only event, please visit:
Fireside Chat Registration Link
The replay of the fireside chat will be available under "Events" on Ainos' investor relations website at https://ir.ainos.com/.
About AI Nose
AI Nose digitizes scent into Smell ID, an AI-driven scent intelligence. This full-stack electronic nose (e-nose) platform combines precision MEMS sensor arrays with proprietary AI algorithms, aiming to detect scent at parts-per-billion (ppb) sensitivity. Smell ID then converts analog scent data into actionable insights, while the proprietary smell language model (SLM) learns complex scent patterns. Backed by a 13-year scent data moat and deep medtech expertise, AI Nose aims to deliver continuous monitoring, predictive analytics, and instant alerts to boost safety, quality, and efficiency. To be delivered as SmellTech-as-a-Service, it aims to offer subscription access to ongoing scent intelligence, analytics, and real-time alerts, turning the invisible into strategic advantage.
About Ainos, Inc.
Ainos, Inc. (NASDAQ:AIMD) is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA®, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. Ainos, a fusion of "AI" and "Nose," is redefining machine perception for the sensory age. To learn more, visit https://www.ainos.com. Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.
Forward-Looking Statements
Certain statements in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements are based on management's current assumptions and expectations of future events and trends, which affect or may affect the Company's business, strategy, operations or financial performance, and actual results and other events may differ materially from those expressed or implied in such statements due to numerous risks and uncertainties. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. There are a number of important factors that could cause actual results, developments, business decisions or other events to differ materially from those contemplated by the forward-looking statements in this press release. These factors include, among other things, our expectation that we will incur net losses for the foreseeable future; our ability to become profitable; our ability to raise additional capital to continue our product development; our ability to accurately predict our future operating results; our ability to advance our current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates we develop; the ability to obtain and maintain regulatory approval of our product candidates; delays in completing the development and commercialization of our current and future product candidates; developing and commercializing additional products, including diagnostic testing devices; our ability to compete in the marketplace; compliance with applicable laws, regulations and tariffs, and factors described in the Risk Factors section of our public filings with the Securities and Exchange Commission (SEC). Because forward-looking statements are inherently subject to risks and uncertainties, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this press release and, except to the extent required by applicable law, the Company undertakes no obligation to update or revise these statements, whether as a result of any new information, future events and developments or otherwise.
Contact Information:
Feifei Shen
[email protected]
SOURCE: Ainos, Inc.
View the original press release on ACCESS Newswire
B.Finley--AMWN